Oral vs. Injectable Semaglutide: How Do They Compare in the Real World?
Real-world data from a single center compared oral and injectable semaglutide for blood sugar and weight outcomes in type 2 diabetes.
Quick Facts
What This Study Found
First real-world comparison of oral vs. injectable semaglutide for HbA1c and weight reduction in type 2 diabetes patients.
Key Numbers
Retrospective single-center study. Patients on oral or injectable semaglutide (Nov 2019-Jul 2022). Compared HbA1c and weight changes at 6 months, stratified by dose.
How They Did This
Retrospective single-center chart review comparing oral and injectable semaglutide outcomes at 6 months.
Why This Research Matters
Clinicians and patients assume oral and injectable semaglutide are interchangeable, but real-world data to support this has been lacking.
The Bigger Picture
As patients increasingly switch between oral and injectable semaglutide, understanding their comparative real-world effectiveness is essential for clinical decisions.
What This Study Doesn't Tell Us
Retrospective single-center study — subject to selection bias, confounding, and limited generalizability.
Questions This Raises
- ?Do formulation-switching patients maintain the same outcomes?
- ?Would a larger multi-center study confirm these findings?
Trust & Context
- Key Stat:
- 6 months Follow-up period comparing HbA1c and weight changes between oral and injectable semaglutide
- Evidence Grade:
- Retrospective single-center review — useful real-world evidence but lower quality than randomized controlled trials.
- Study Age:
- Published in 2025, filling a gap in head-to-head formulation comparison data.
- Original Title:
- Real-World Comparison of Oral Versus Injectable Semaglutide for the Reduction of Hemoglobin A1C and Weight in Patients with Type 2 Diabetes.
- Published In:
- The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 41(1), 22-31 (2025)
- Authors:
- Pinto, Maria, Brennan, Lillian, Diehl, Katie, Lin, Shally, Heacock, Samantha
- Database ID:
- RPEP-13059
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Are oral and injectable semaglutide equally effective?
This real-world study compared the two formulations directly — previously no head-to-head data existed to answer this question.
Can I switch from injectable to oral semaglutide?
Many patients do switch formulations. This study helps inform whether outcomes remain comparable in real-world practice.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13059APA
Pinto, Maria; Brennan, Lillian; Diehl, Katie; Lin, Shally; Heacock, Samantha. (2025). Real-World Comparison of Oral Versus Injectable Semaglutide for the Reduction of Hemoglobin A1C and Weight in Patients with Type 2 Diabetes.. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 41(1), 22-31. https://doi.org/10.1177/87551225241289959
MLA
Pinto, Maria, et al. "Real-World Comparison of Oral Versus Injectable Semaglutide for the Reduction of Hemoglobin A1C and Weight in Patients with Type 2 Diabetes.." The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2025. https://doi.org/10.1177/87551225241289959
RethinkPeptides
RethinkPeptides Research Database. "Real-World Comparison of Oral Versus Injectable Semaglutide ..." RPEP-13059. Retrieved from https://rethinkpeptides.com/research/pinto-2025-realworld-comparison-of-oral
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.